See the DrugPatentWatch profile for Nubain
What drug class is Nubain?
Nubain is the brand name for nalbuphine, an opioid medicine. It belongs to the class of opioid analgesics and is specifically a mixed agonist–antagonist opioid (an opioid that activates some opioid receptors while blocking others) [1].
What does “mixed agonist–antagonist” mean for Nubain?
Because nalbuphine is a mixed agonist–antagonist, it can provide pain relief like a traditional opioid, but it tends to have a different opioid effect profile than pure opioid agonists (such as morphine). This receptor activity is part of why it’s used for pain and is also relevant to how it affects breathing and opioid “strength”/effects compared with full agonists [1].
What is Nubain typically used for?
Nubain (nalbuphine) is used as an opioid pain reliever in clinical settings. Exact uses depend on local prescribing practices and labeling, but its role is generally management of moderate to severe pain [1].
Is Nubain related to other opioids?
Yes. Nubain is in the opioid family (nalbuphine), but it is not the same class as pure opioid agonists. Its mixed agonist–antagonist mechanism differentiates it from drugs that only stimulate opioid receptors [1].
What are common patient concerns with opioid medicines like Nubain?
As with other opioid analgesics, key concerns usually include sedation, constipation, and risk of respiratory depression, especially at higher doses or when combined with other depressants. Because Nubain’s receptor behavior differs from pure agonists, it can still carry opioid risks even though its pharmacology is not identical to drugs like morphine [1].
Sources
- https://www.drugs.com/nubain.html